Government Approves First Ever Drug In
U.S. With Digital Tracking System
WASHINGTON (AP) - The Food and Drug
Administration has approved the first drug in the United States with a
digital ingestion tracking system in an unprecedented step to ensure
that patients with mental disorders take the medicine prescribed for
them.
The drug Abilify MyCite was developed by Otsuka Pharmaceutical Co., Ltd.
Abilify was first approved by the FDA in 2002 to treat schizophrenia,
and the ingestible sensor, made by Proteus Digital health, was initially
approved for marketing in 2012. The agency says the digitally enhanced
medication "works by sending a message from the pill's sensor to a
wearable patch."
Dr. Mitchell Mathis of the FDA says officials support "use of new
technology in prescription drugs and is committed to working with
companies to understand how the new technology might benefit patients
and prescribers."